6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins
Na. Muma et al., 6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins, EXP NEUROL, 168(1), 2001, pp. 135-143
The neuropathological hallmarks of many neurodegenerative diseases are intr
aneuronal inclusions containing cytoskeletal proteins such as neurofilament
s in Lewy bodies in Parkinson's disease and tau in neurofibrillary tangles
in Alzheimer's disease. Dysfunction in dopaminergic and cholinergic systems
also exist in both Alzheimer's disease and Parkinson's disease. Because th
e primary pathology in Parkinson's disease is localized to the dopaminergic
system, we set out to determine if perturbations in cholinergic systems ar
e a consequence of dopaminergic neuron loss. Therefore, following intracere
bral microinjections of 6-hydroxydopamine in rats, the activity of choliner
gic neurons was measured by hemicholinium binding in cholinergic terminal f
ields and perturbations in cytoskeletal proteins were examined in dopaminoc
eptive neurons using immunocytochemistry. The 6-hydroxydopamine injections
robustly reduced the number of monoaminergic cell bodies in the lateral mid
brain and dramatically decreased dopamine and its major metabolites in dopa
minergic projection sites. This treatment increased hemicholinium binding i
n the prefrontal cortex (200%) and amygdala (284%); however, despite previo
us reports to the contrary, there were no increases in immunoreactivity for
phosphorylated neurofilaments, microtubule-associated protein (MAP) 2, tau
or paired helical filament (PHF) tau. This lack of an increase in cytoskel
etal proteins was observed following either injections of moderate doses of
the toxin directly into the medial forebrain bundle or after high doses we
re administered intracerebroventricularly. These results suggest that remov
al of dopaminergic inputs to the forebrain results in hyperactivity of the
cholinergic systems but is not sufficient to induce postsynaptic perturbati
ons in cytoskeletal proteins which occur in neurodegenerative diseases. (C)
2001 Academic Press.